| Jennifer Rose Durham, APN | |
|
10003 Webster Rd, Camden On Gauley, WV 26208-7713 | |
| (304) 226-5725 | |
| (304) 226-3274 |
| Full Name | Jennifer Rose Durham |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 10003 Webster Rd, Camden On Gauley, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629403563 | NPI | - | NPPES |
| WV3488A | Other | WV | MEDICARE |
| 3810026528 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 73253 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Webster County Memorial Hospital | Webster springs, WV | Hospital |
| Summersville Regional Medical Center | Summersville, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Camden On Gauley Medical Center Inc | 6002867850 | 18 |
News Archive
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
A listener asked: 'How do I remain cool when calling insurance companies?" So we called veteran self-defense teacher Lauren Taylor for advice. She leads Defend Yourself, an organization that works to empower people against violence and abuse.
Jason Zaremski, MD presented a research abstract about the importance of considering practice and warm-up pitches in total pitch counts at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL.
› Verified 8 days ago
| Entity Name | Camden On Gauley Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861872541 PECOS PAC ID: 6002867850 Enrollment ID: O20160125000001 |
News Archive
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
A listener asked: 'How do I remain cool when calling insurance companies?" So we called veteran self-defense teacher Lauren Taylor for advice. She leads Defend Yourself, an organization that works to empower people against violence and abuse.
Jason Zaremski, MD presented a research abstract about the importance of considering practice and warm-up pitches in total pitch counts at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL.
› Verified 8 days ago
| Entity Name | Camden On Gauley Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174065916 PECOS PAC ID: 6002867850 Enrollment ID: O20170613000749 |
News Archive
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
A listener asked: 'How do I remain cool when calling insurance companies?" So we called veteran self-defense teacher Lauren Taylor for advice. She leads Defend Yourself, an organization that works to empower people against violence and abuse.
Jason Zaremski, MD presented a research abstract about the importance of considering practice and warm-up pitches in total pitch counts at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL.
› Verified 8 days ago
| Entity Name | Camden On Gauley Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811420250 PECOS PAC ID: 6002867850 Enrollment ID: O20180123000206 |
News Archive
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
A listener asked: 'How do I remain cool when calling insurance companies?" So we called veteran self-defense teacher Lauren Taylor for advice. She leads Defend Yourself, an organization that works to empower people against violence and abuse.
Jason Zaremski, MD presented a research abstract about the importance of considering practice and warm-up pitches in total pitch counts at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL.
› Verified 8 days ago
| Entity Name | Camden On Gauley Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700312618 PECOS PAC ID: 6002867850 Enrollment ID: O20180413002227 |
News Archive
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
A listener asked: 'How do I remain cool when calling insurance companies?" So we called veteran self-defense teacher Lauren Taylor for advice. She leads Defend Yourself, an organization that works to empower people against violence and abuse.
Jason Zaremski, MD presented a research abstract about the importance of considering practice and warm-up pitches in total pitch counts at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL.
› Verified 8 days ago
| Entity Name | Camden On Gauley Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508372228 PECOS PAC ID: 6002867850 Enrollment ID: O20190208001062 |
News Archive
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
A listener asked: 'How do I remain cool when calling insurance companies?" So we called veteran self-defense teacher Lauren Taylor for advice. She leads Defend Yourself, an organization that works to empower people against violence and abuse.
Jason Zaremski, MD presented a research abstract about the importance of considering practice and warm-up pitches in total pitch counts at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL.
› Verified 8 days ago
| Entity Name | Camden On Gauley Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669947222 PECOS PAC ID: 6002867850 Enrollment ID: O20200423002284 |
News Archive
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
A listener asked: 'How do I remain cool when calling insurance companies?" So we called veteran self-defense teacher Lauren Taylor for advice. She leads Defend Yourself, an organization that works to empower people against violence and abuse.
Jason Zaremski, MD presented a research abstract about the importance of considering practice and warm-up pitches in total pitch counts at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL.
› Verified 8 days ago
| Entity Name | Camden On Gauley Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215394648 PECOS PAC ID: 6002867850 Enrollment ID: O20200429000282 |
News Archive
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
A listener asked: 'How do I remain cool when calling insurance companies?" So we called veteran self-defense teacher Lauren Taylor for advice. She leads Defend Yourself, an organization that works to empower people against violence and abuse.
Jason Zaremski, MD presented a research abstract about the importance of considering practice and warm-up pitches in total pitch counts at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL.
› Verified 8 days ago
| Entity Name | Camden On Gauley Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801493499 PECOS PAC ID: 6002867850 Enrollment ID: O20230629001639 |
News Archive
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
A listener asked: 'How do I remain cool when calling insurance companies?" So we called veteran self-defense teacher Lauren Taylor for advice. She leads Defend Yourself, an organization that works to empower people against violence and abuse.
Jason Zaremski, MD presented a research abstract about the importance of considering practice and warm-up pitches in total pitch counts at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Rose Durham, APN 10003 Webster Rd, Camden On Gauley, WV 26208-7713 Ph: (304) 226-5725 | Jennifer Rose Durham, APN 10003 Webster Rd, Camden On Gauley, WV 26208-7713 Ph: (304) 226-5725 |
News Archive
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
A listener asked: 'How do I remain cool when calling insurance companies?" So we called veteran self-defense teacher Lauren Taylor for advice. She leads Defend Yourself, an organization that works to empower people against violence and abuse.
Jason Zaremski, MD presented a research abstract about the importance of considering practice and warm-up pitches in total pitch counts at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL.
› Verified 8 days ago
Milissa K Short, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10003 Webster Road, Camden On Gauley, WV 26208 Phone: 304-226-5725 Fax: 304-226-3274 | |
Mrs. Heather Dawn Glasko-tully, MSN, APRN, NP-C, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10003 Webster Rd, Camden On Gauley, WV 26208 Phone: 304-226-5725 | |
Kara Holdren, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10003 Webster Rd, Camden On Gauley, WV 26208 Phone: 304-226-5725 | |
Tonya Rachel Young, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10003 Webster Rd, Camden On Gauley, WV 26208 Phone: 304-226-5725 Fax: 304-226-3274 | |
Kimberly J Angus, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10003 Webster Road, Camden On Gauley, WV 26208 Phone: 304-226-5725 Fax: 304-226-3274 | |
Anna Marie Philpott, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10003 Webster Rd, Camden On Gauley, WV 26208 Phone: 304-226-5725 | |
Mrs. Paula Michelle Brammer, RN, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10003 Webster Rd, Camden On Gauley, WV 26208 Phone: 304-226-5725 |